Jul 4, 2024, 12:15
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“Last session of the day on Precision Medicine in European Network for the Study of Cholangiocarcinoma (ENS-CCA), Precision-BTC-Network joint meeting in Krakow.
- surgical candidates
- neoadjuvant
- chemoresistance?
- markers for IO
- new markers- circRNAs
We MUST validate innovate biomarkers in clinical trials.”
Source: Angela Lamarca/X
Angela Lamarca
biomarkers
cancer
Chemoresistance
cholangiocarcinoma
circRNAs
clinical trials
ENS-CCA
European Network for the Study of Cholangiocarcinoma
HPB Oncologist
immunotherapy
Jimenez Diaz Foundation
neoadjuvant therapy
NET Oncologist
OncoDaily
Oncology
Precision Medicine
Precision-BTC-Network
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:12
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25